FDA Approved: ALLI — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for Alli (orlistat) submitted by Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ALLI (orlistat)

Snippet

SUPPL AP for ALLI (ORLISTAT)